You are Here : Moneycontrol Markets IPO Remus Pharmaceuticals
Description Remus focuses on marketing, distributing and exporting top-of-the-line complex generics certified by regulatory authorities. Backed by expert scientists, they make “healing through medicines” globally affordable. For over a decade, Remus has been at the forefront of critical healthcare globally..... More »
Address 1101 to 1103 South Tower One42, B/H Ashok Vatika Amblibopal Rd , Ahmeda Gujarat , India Pincode : 380054
Issue price / Floor Price (Rs) | 1,150.00-1,229. |
Application per share (Rs) | 1,229.00 |
Minimum investment amount (Rs) | 122,900.00 |
Minimum bid (no of shares) | 100 |
Maximum Shares for Retail | N.A. |
Issue opens | 17-May-23 |
Issue closes | 19-May-23 |
Listing on | NSE - SME |
Issue size (Rs cr) | 44.62 - 47.69 |
Mkt cap at issue price (Rs cr) | N.A. |
Lead Manager |
---|
BEELINE CAPITAL ADVISORS PRIVATE LIMITED | mb@beelinemb.com |
Registrar | LINK INTIME INDIA PRIVATE LIMITED |
remuspharmaceuticals.ipo@linkintime.co.in |
Shares on Offer | Lakhs |
---|---|
Total shares offered | N.A. |
Of above, offered to public | N.A. |
Post-issue shares | N.A. |
Post-issue promoters' holding(%) | N.A. |
Financials | Crore |
---|---|
No of months | N.A. |
Turnover | N.A. |
Net profit / (loss) | N.A. |
Borrowings | N.A. |